Downloaded from ijdld.tums.ac.ir at 19:13 IRDT on Friday May 4th 2018
|
|
- Janel Davis
- 6 years ago
- Views:
Transcription
1 - : -. : - 3 *. () - : : (LDL-C) (HDL-C) TG/HDL-)HDL-C TG (TC/HDL-C)HDL-C (HRs) TC (non- HDL-C) (TG) (TC) HDL. 8/4. HR. ( 98 9). TG/HDL-C (C 89 : HDL-C.[/3 (/0 -/57)] TC/HDL-C. ( C ) WHO non-hdl- HR TC/HDL-C non-hdl-c LDL-C TC. C /30 /0 HR. : LDL-C TC. TC/HDL-C C - : : - : - : : tohidi@endocrine.ac.ir 88//9 : 88//8 : 88/9/0:
2 : /5 /7.[0-]. ) 030 ([3]. C. [4]. (TLGS) TLGS TLGS ) 3 (380.[5 9] 30 ( ) ( 6) ( ) 0. ( 8/4 )387 -Discrimination power (CHD) Haffner.[ ] (MI).[3] MI MI CHD : 3 (TG) [4] 4 (HDL-C) 6 5.[5] (LDL-C) 7 (VLDL) 8.non-HDL-C (IDL) B 9 () -.[7 6] LDL-C Health professional s Follow- up 0 HDL-C (TC).[7].[8] (TLGS).[9] -Coronary heart disease (CHD) -Myocardial infarction (MI) 3-Triglycerides (TG) 4-High density lipoprotein- cholesterol (HDL-C) 5-Low density lipoprotein- cholesterol (LDL-C) 6-Altered composition 7-Very low density lipoprotein (VLDL) 8-Intermediate density lipoprotein (IDL) 9-Cardiovascular disease () 0-Cholesterol (TC) -Tehran lipid & glucose study (TLGS)
3 C. HDL TG. B. ( ) Vital Sceintific, Spankeren, The ) - TG. (Netherlands [6 ] LDL - C mg/dl 400 HDL -C non-hdl-c. TC/HDL-C TG/HDL - C. TC. HDL-C TC TG %/ HDL-C TC. TG. % 0/5.[5 9] % /6 0/6 - -.[7]... - (ECG) ] MI ECG ) MI [ [8] ( ECG ) ( ECG (m ) (kg) (BMI).. (cm) (cm) (WHR) TLGS.. 3 (OGTT) TC. -Body Mass Index (BMI) -Waist to Hip Ratio (WHR) 3-Oral Glucose Tolerance Test (OGTT)
4 : ). (387. ] 6 (SBP) FPG WHR 7 (DBP) [ P- 0/ value p stepwise backward multivariate Cox regression. 0/ SBP FPG. SBP FPG WHR WHR. SBP FPG. 8 (HRs). SD %95 9 Cox. 0. Criteria. Akaike Information (AIC).[] AIC [4] C 0/5 ) CHD ( 4. (FPG) 6 (mg/dl) [9] 00 mg/dl ":. " ( ) (WHO).[0] 4 (SD) ±. TG/HDL-C TG FPG. ( ) t Systolic blood pressure (SBP) 7-Diastolic blood pressure (DBP) 8-Hazard ratio (HR) 9-The proportional hazard assumption) 0-Schoenfild residual test -Goodness of fit -Fasting plasma glucose (FPG) -Milligram per deciliter (mg/dl) 3-World Health Organization (WHO) 4-Standard deviation(sd) 5-Cox Proportional Hazard Model
5 -. 9 SBP FPG ). ( %45 6 SD -. non-hdl- LDL-C TC SD TG/HDL-C TC/HDL-C C. - SD P=0/06] %9 HDL-C. - [0/8 (0/65-/0) TC/HDL-C [/3 (/0-/57) P=0/00] non- LDL-C SD P=0.00]. %8 HDL-C non-hdl-c LDL-C. α= 0/05 SD /30 /0. %74 %30. HDL-C SD [0/84 (0/7-/00) P =0/05 ] %6 HR. TC/HDL-C non-hdl-c LDL-C TC -C HR =/0).(LDL-C /30 TC/HDL ".( C P >0/) C %95 STATA C. Somersd.[] Jackknife (0 ) STATA. 0/05 P ( 53/4 56/6 ) 89 8/4.. - ( 98 9). non- LDL-C TC FPG DBP SBP WHR TC/HDL-C HDL-C WHR. TC/HDL -C non-hdl-c TG LDL-C TC FPG SBP. TG/HDL-C SD. TC TC/HDL-C TG LDL-C.
6 : non-hdl-c LDL-C TC TC/HDL-C TG <00 mg/dl TG 00mg/dL. 00 mg/dl TG TG.(4 ) TG P ) (Interaction).( 0/05 57±8 3/6 4/ /3 4/5 4/8 66/3 9/7±4/5 0/93±0/08 43/7±4/6 85/6±/9 6(5-7) 59/5±5/6 68/4±43/0 4(35-49) 7(70-307) 7/±5/ 5/(3/8-8/4) 6/5±/3 AIC. LDL-C LDL- TC/HDL-C non-hdl-c LDL-C. C TC/HDL-C. HDL-C non-hdl-c Non-. LDL-C AIC AIC TC/HDL -C HDL-C. TC LDL-C - - 5±0 3/ 5/7 6/9 0/6 /3 45/ 9/7±5/3 0/90±0/07 3/7±/8 83/0±0/3 30(07-77) 38/5±49/ 50/±39/ 4(35-49) 99(45-78) 94/3±48/4 4/6(3/-7/) 5/7±/7 59±0 5/4 46/ 8/4 8/9 5/ /0±3/5 0/99±0/06 43/±7/4 85/6±5/ 46(-05) 38/0±5/8 5/3±4/9 35(3-4) 33(53-308) 99/0±49/9 6/(4/3-9/3) 6/7±/ 55± /5 43/8 6/4 5/0 8/ /3±3/9 0/96±0/07 9/3±9/7 80/5±0/9 97(0-7) 7/5±4/7 34/7±35/ 35(3-4) 0(44-93) 79/7±4/6 5/5(3/8-8/9) 6/±/ ( ) (kg/m ) (mmhg) (mmhg) (mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl) / /. 0/05 P...( 9) 43 ( 98) : ±. ) /. - t. (.
7 AIC ( %95) C 0/70(0/65-0/75) 0/70(0/65-0/76) 0/68(0/6-0/73) 0/70(0/65-0/75) 0/68(0/63-0/74) 0/69(0/64-0/74) 0/68(0/6-0/73) 0/73(0/68-0/77) 0/73(0/68-0/78) 0/73(0/68-0/77) 0/73(0/69-0/78) 0/7(0/67-0/77) 0/74(0/70-0/79) 0/7(0/68-0/77) /39(/5-/70) /45(/6-/83) 0/9(0/7-/6) /36(/4-/63) /0(/0-/43) /6(/0-/33) /06(0/9-/3) /3(0/93-/37) /8(0/97-/44) 0/8(0/66-/0) /8(0/98-/4) /0(0/84-/3) /3(/0-/57) /3(0/95-/34) /46(/-/75) /47(/8-/83) 0/90(0/7-/) /45(/0-/74) /(/03-/44) /8(/04-/34) /09(0/94-/6) /3(/-/57) /33(/-/59) 0/8(0/65-/0) /37(/6-/6) /09(0/94-/6) /44(/4-/68) /(/05-/40) / / / /. 0/05 P.... ( SBP) ( FPG) SBP FPG (WHR) Akaike Information Criteria (AIC). - C. AIC.. 0/5-3 AIC ( %95) C 366 0/73(0/70-0/76) /5(0/09-/43) /40(/3-/59) 979 0/73(0/70-0/77) /30(/-/50) /40(/-/6) 346 0/7(0/68-0/75) 0/86(0/7-/0) 0/84(0/7-/00) 338 0/73(0/70-0/76) /6(/0-/44) /4(/4-/59) 374 0/7(0/68-0/75) /(0/98-/6) /5(/03-/8) 338 0/73(0/70-0/76) /0(/0-/3) /3(/4-/34) / 347 0/7(0/68-0/75) /08(0/98-/9) /08(0/98-/9 /. 0/05 P.... Criteria (AIC) Akaike Information. 0/5 C. AIC.
8 : mg/dl 00-4 mg/dl00 > mg/dl00 /40(/04-/89) /3(/03-/45 /39(/07-/8) /30(/07-/57) /46(/09-/97) /4(/04-/47) /74(/9-/55) /8(/05-/33) /. 0/05 P... LDL-C TC.[4 3] LDL- C TC LDL-C AIC. CHD %4 TC SD.[5] (3-63% : %95 ). (3-59%) %40 LDL-C TC TC TG.[6]. LDL- C %0/7 ) LDL-C ( 400mg/dl TG.[7] TC non- HDL-C.[8 7 6] ) LDL-C TC.[9] TC/HDL-C ( Health Professional s follow-up Study. TC/HDL-C TG non- HDL-C LDL-C TC. ( C ) LDL-C ( AIC ) TC TC/HDL-C non- HDL -C TG. TG %9 HDL-C SD ).( TC/HDL-C. LDL-C non- TC/HDL-C. HDL-C TC/HDL-C non- HDL-C LDL-C TC.(%73 C ) -Asia Pacific Cohort Studies Collaboration -Multivariate adjusted sex pooled analysis
9 -. 96 TG. AIC Strong Health Professionals, Follow-up Study TG Heart.[7 6] - non- LDL-C TC TLGS TC/HDL-C HDL-C -.[7] TG HDL-C TC. 3 TG.[3] HDL-C TG TG TG ApoB Apo A-. Ingelsson. CHD ApoB/apoA.[3] TC/HDL-C ( HbAC). [33] 30 non-hdl- LDL-C C TC/HDL-C.[7] HR Strong Heart (tertile) non- HDL-C HR. TG LDL-C TC/HDL-C.[6] non-hdl-c TC/HDL-C non-hdl-c LDL-C. AIC TC/HDL-C non-hdl-c TC/HDL-C C UKPDS.[30] non-hdl-c TG Strong Heart.[7 6] TC/HDL-C.[6] TG TG HDL-C Nurses, Health. TG HDL-C 0 Schulze.[8] HDL-C TG HbAC.[8] %0 TG SD [ HR /0 (/0-/43) P =0/04] 3-Rregression dilution -Nested models -U.K Prospective Diabetes Study (UKPDS)
10 : HDL-C LDL-C TG TC.[34] WHO TC TC/HDL-C non- HDL-C LDL-C.... Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 998; 97: Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the U.S. population, Diabetes Care 998; : Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 998; 339: Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 993; 36: OGTT..[5]. Ingelsson (C ).[3] TC) (non- HDL-C TC/HDL/C TC WHO.[3] 5. Barrett-Connor E, Grundy SM, Holdbrook MJ: Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 98; 5: Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ: Non-HDL cholesterol as a predictor of cardiovascular disease in type diabetes: the strong heart study. Diabetes Care 003; 6: Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB: Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type diabetes. Diabetes Care 004; 7: Howard BV, Robbins DC, Sievers ML, Lee ET, Rhoades D, Devereux RB et al: LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler Thromb Vasc Biol 000; 0: Azizi F, Rahmani M, Emami H, Madjid M: Tehran Lipid and Glucose Study: rationale and design. Prevention 000; 3:4-47.
11 Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F: High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health 008; 8:76.. Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, Azizi F: Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest Harati H, Hadaegh F, Saadat N, Azizi F: Population-based incidence of Type diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health 009; 9: Hossain P, Kawar B, El Nahas M: Obesity and diabetes in the developing world--a growing challenge. N Engl J Med 007; 356: Pencina MJ, D Agostino RB: Overall C as a measure of discrimination in survival analysis:model specific population value and confidence interval estimation. Statist Med 004; 3: Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M: Prevention of noncommunicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 009; 0:5. 6. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 97; 8: Hadaegh F, Harati H, Ghanbarian A, Azizi F: Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 006; 3: Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D et al: Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 003; 08: Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R et al: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 003; 6: NIH Consensus and State-of-the-Science Statements. 005, Volume, Number.. Agresti A: Building and Applying Logistic Regression Models: AN introduction to categorical Data Analysis.th ed. John Wiley &Sons, Inc, Hoboken, New Jersey Roger N: Parameters behind "nonparametric" statistic: Kendall's tau, Somers'D and median differences. STATA J 00; : Kannel WB, Castelli WP, Gordon T: Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 979; 90: Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 3). BMJ 998; 36: Asia Pacific Cohort Studies Collaboration. Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region. Diabetologia 007; 50: Anderson KM, Wilson PW, Odell PM, Kannel WB: An updated coronary risk profile. A statement for health professionals. Circulation 99, 83: Homma Y: Predictors of atherosclerosis. J Atheroscler Thromb 004; : Schulze MB, Shai I, Manson JE, Li T, Rifai N: Joint role of non-hdl cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type diabetes. Diabetologia 004; 47: Wang CY, Chang TC: Non-HDL cholesterol level is reliable to be an early predictor for vascular inflammation in type diabetes mellitus. J Clin Endocrinol Metab 004; 89: Holman RR, Coleman RL, Shine BS, Stevens RJ: Non-HDL cholesterol is less informative than the total-to-hdl cholesterol ratio in predicting cardiovascular risk in type diabetes. Diabetes Care 005; 8: Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G: Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 004; 0: Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ et al: Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 007; 98: American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 009; :S WHO -Risk Management Package for low- and medium-resource settings. /management/ package/en/. Geneva: World Health Organization; 00.
CVD.
149-158(2 )8 1387. - : () - :. : (HR)... () :... [HR: /(CI: / )] [HR:/(/-/) ]... :. - : - : : - : - : - fzhadaegh@endocrine.ac.ir 87/9/11: 87/8/29 : 87/7/3 : ... - : 15 TLGS.. ) -. ( (OGTT) ( ).. ( / )...
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More information. Non HDL-c : Downloaded from ijdld.tums.ac.ir at 18:05 IRDT on Friday March 22nd Non HDL LDL. . LDL Non HDL-c
208-23 (2 ) 0 389 -. Non HDL * Downloaded from ijdld.tums.ac.ir at 8:05 IRDT on Friday March 22nd 209 Non HDL : LDL.. 5 3277 :.. odds ratio Chi-Square %3/9 Non HDL-C %2 LDL-C. %3 : Non-HDL-C LDL-C. (CI
More informationAn Overview on Cardiovascular Risks Definitions by Using Survival Analysis Techniques-Tehran Lipid and Glucose Study: 13-Year Follow-Up Outcomes
Global Journal of Health Science; Vol. 9, No. 4; 2017 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education An Overview on Cardiovascular Risks Definitions by Using Survival
More informationIsolated Post-challenge Hyperglycemia: Concept and Clinical Significance
CLINICAL PRACTICE Isolated Post-challenge Hyperglycemia: Concept and Clinical Significance John MF. Adam*, Daniel Josten** ABSTRACT The American Diabetes Association has strongly recommended that fasting
More informationAtherosclerotic Disease Risk Score
Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,
More informationElevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes FRANK B. HU, MD 1,2,3 MEIR J. STAMPFER,
More informationImpact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose study
Khaloo et al. Nutrition & Metabolism (2018) 15:50 https://doi.org/10.1186/s12986-018-0287-6 RESEARCH Open Access Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes:
More informationIdentification of subjects at high risk for cardiovascular disease
Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet
More informationOn May 2001, the Third Adult
THE RISK OF DIABETES: CAN WE IMPACT CHD THROUGH THE ATP III CHOLESTEROL GUIDELINES? * Based on a presentation given by Steven M. Haffner, MD, MPH ABSTRACT Diabetes has been recognized among diabetologists
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationKey words: Ageing, Cardiovascular disease, Epidemiology, Insulin resistance
142 Metabolic Syndrome in Elderly Population Farzad Hadaegh et al Original Article Prevalence of Metabolic Syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationDYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid
Malaysian Journal of Medical Sciences, Vol. 11, No. 1, January 2004 (44-51) ORIGINAL ARTICLE DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul
More informationDownloaded from ijdld.tums.ac.ir at 16:29 IRDT on Friday March 22nd 2019
560-567 (5 ) 0 390 -. : 4 3 2 Downloaded from ijdld.tums.ac.ir at 6:29 IRDT on Friday March 22nd 209. :.. 30 :. 7042 8 HDL-C LDL-C. HDL-C LDL-C. Backward 398. 3074 (% 43/7) 44 : 6 (kg/m 2 ) 27 68 237.
More informationIschemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010
Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationHyperlipidemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
...PRESENTATIONS... Hyperlipidemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes Based on a presentation by Ronald B. Goldberg, MD Presentation Summary Atherosclerosis accounts for approximately
More informationMetabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study. Arab Medical University. Benghazi, Libya
Original Article Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study Alshkri MM 1, Elmehdawi RR 2 1 Benghazi Diabetes Center. 2 Medical Department, Faculty of Medicine,
More informationTriglycerides and triglycerides to high-density lipoprotein cholesterol ratio are strong predictors of incident hypertension in Middle Eastern women
(2012) 26, 525 532 & 2012 Macmillan Publishers Limited All rights reserved 0950-9240/12 www.nature.com/jhh ORIGINAL ARTICLE Triglycerides and triglycerides to high-density lipoprotein cholesterol ratio
More informationComparison of a Homogeneous Assay With a Precipitation Method for the Measurement of HDL Cholesterol in Diabetic Patients
Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E Comparison of a Homogeneous Assay With a Precipitation Method for the Measurement of HDL Cholesterol in Diabetic Patients TONNY JENSEN, MD
More informationAssociation of Cardiovascular Risk Factors in Hypertensive Subjects with Metabolic Syndrome De ned by Three Different De nitions
ORIGINAL ARTICLE J Nepal Med Assoc 2011;51(184):157-63 Association of Cardiovascular Risk Factors in Hypertensive Subjects with Metabolic Syndrome De ned by Three Different De nitions Shrestha R 1, Jha
More informationJoint role of non-hdl cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes
Diabetologia (2004) 47:2129 2136 DOI 10.1007/s00125-004-1593-2 Joint role of non-hdl cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes
More informationNon-HDL Cholesterol and Apolipoprotein B Predict Cardiovascular Disease Events Among Men With Type 2 Diabetes
Pathophysiology/Complications O R I G I N A L A R T I C L E Non-HDL Cholesterol and Apolipoprotein B Predict Cardiovascular Disease Events Among Men With Type 2 Diabetes RUI JIANG, MD, DRPH 1,2 MATTHIAS
More informationThe Framingham Risk Score (FRS) is widely recommended
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore
More informationKatsuyuki Nakajima, PhD. Member of JCCLS International Committee
Katsuyuki Nakajima, PhD Member of JCCLS International Committee Visiting Professor and Scientist Tufts University, Boston, MA & Framingham Offspring Study, Framingham, MA August 20 th, 2011, Tokyo Framingham
More informationNormal Fasting Plasma Glucose and Risk of Type 2 Diabetes Diagnosis
CLINICAL RESEARCH STUDY Normal Fasting Plasma Glucose and Risk of Type 2 Diabetes Diagnosis Gregory A. Nichols, PhD, Teresa A. Hillier, MD, MS, Jonathan B. Brown, PhD, MPP Center for Health Research, Kaiser
More informationYOUNG ADULT MEN AND MIDDLEaged
BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,
More informationPlasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension
World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original
More informationDiabetologia 9 Springer-Verlag 1991
Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease
More informationTrends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study
RESEARCH ARTICLE Trends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study Younes Jahangiri-Noudeh 1, Samaneh Akbarpour 1, Mojtaba Lotfaliany
More informationNon-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes
Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes The Strong Heart Study WEIQUAN LU, MD HELAINE E. RESNICK,
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationEpidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl
Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk Eberhard Standl European Heart House Sophia Antipolis Thursday, June 17, 2010 IDF Diabetes Atlas 2009: Global Numbers Still
More informationSoo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital
Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital 1. Importance of Lowering LDL-Cholesterol in Diabetes Patients & Lipid Guidelines Prevalence of dyslipidemia in Korea Prevalence
More informationMafauzy Mohamed, Than Winn, GR Lekhraj Rampal*, Abdul Rashid AR, Mustaffa BE
Malaysian Journal of Medical Sciences, Vol. 12, No. 1, January 2005 (20-25) ORIGINAL ARTICLE A PRELIMENARY RESULT OF THE CARDIOVASCULAR RISK FACTORS INTERVENTION STUDY (PIKOM STUDY): DIABETES MELLITUS,
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationUnraveling the concealed and calculated cardiovascular risks in diabetes
15 P B Fernando Memorial Oration 2015 Unraveling the concealed and calculated cardiovascular risks in diabetes Weerarathna T P 1 Journal of the Ceylon College of Physicians, 2016, 47, 15-19 Abstract Cardiovascular
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationAssessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients. Copyright. Not for Sale or Commercial Distribution
CLINICAL Viewpoint Assessing Cardiovascular Risk to Optimally Stratify Low- and Moderate- Risk Patients Copyright Not for Sale or Commercial Distribution By Ruth McPherson, MD, PhD, FRCPC Unauthorised
More informationAn individual with undiagnosed diabetes is someone whose diabetes has not. Undiagnosed diabetes: Does it matter? Research Recherche
Undiagnosed diabetes: Does it matter? Research Recherche Dr. Young is Professor and Head, and Dr. Mustard is Associate Professor, Department of Community Health Sciences, University of Manitoba, Winnipeg,
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationAlthough medical advances have curbed
PREVENTION OF CORONARY HEART DISEASE IN THE METABOLIC SYNDROME AND DIABETES MELLITUS * Sherita Hill Golden, MD, MHS ABSTRACT The leading cause of death in patients with diabetes is cardiovascular disease.
More informationInternational Journal of Clinical and Biomedical Research Original Article
ISSN: 2395-0471 International Journal of Clinical and Biomedical Research Original Article STUDY OF HbA1c AS A BIOMARKER IN DYSLIPIDEMIA AND ATHEROGENICITY IN TYPE 2 DIABETES MELLITUS *TIWARI RAJLAXMI
More informationBehind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL
Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:
More informationpatient-oriented and epidemiological research
patient-oriented and epidemiological research Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese Kuo-Liong Chien, 1, *,, Hsiu-Ching Hsu, Ta-Chen
More informationFelix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study
Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Conflict of interest disclosure None Committee of Scientific Affairs Committee
More informationFamily history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study
1 Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands 2 Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands 3 Department of Public Health and
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationAssociation of Plasma Lipid profile and HbA1c among Saudi Patients with Coronary Heart Diseases, at King Abdulaziz Medical City, Riyadh
EUROPEAN ACADEMIC RESEARCH Vol. III, Issue 10/ January 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Association of Plasma Lipid profile and HbA1c among Saudi
More informationHow to Reduce CVD Complications in Diabetes?
How to Reduce CVD Complications in Diabetes? Chaicharn Deerochanawong M.D. Diabetes and Endocrinology Unit Department of Medicine Rajavithi Hospital, Ministry of Public Health Framingham Heart Study 30-Year
More informationMetabolic control and serum lipid changes in diabetic Iraqi men
www.muthjm.com Muthanna Medical Journal 2017; 4(2):56-61 Metabolic control and serum lipid changes in diabetic Iraqi men Aqeel Raheem Hassan 1* Abstract The objective of this study is to demonstrate the
More informationLipoprotein (a): Is it important for Friedewald formula?
ORIGINAL RESEARCH ALBANIAN MEDICAL JOURNAL Lipoprotein (a): Is it important for Friedewald formula? Murat Can 1, Berrak Guven 1 1 Bulent Ecevit University, Faculty of Medicine, Department of Biochemistry
More informationThe investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India
eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,
More informationNew Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines
Clin. Cardiol. Vol. 26 (Suppl. III), III-19 III-24 (2003) New Features of the National Cholesterol Education Program Adult Treatment Panel III Lipid-Lowering Guidelines H. BRYAN BREWER, JR, M.D. Molecular
More informationPredictive value of overweight in early detection of metabolic syndrome in schoolchildren
Predictive value of overweight in early detection of metabolic syndrome in schoolchildren Marjeta Majer, Vera Musil, Vesna Jureša, Sanja Musić Milanović, Saša Missoni University of Zagreb, School of Medicine,
More informationORIGINAL INVESTIGATION. The Impact of Diabetes Mellitus on Mortality From All Causes and Coronary Heart Disease in Women
The Impact of Mellitus on Mortality From All Causes and Coronary Heart Disease in Women 20 Years of Follow-up ORIGINAL INVESTIGATION Frank B. Hu, MD; Meir J. Stampfer, MD; Caren G. Solomon, MD; Simin Liu,
More informationSerum lipoprotein ratios as markers of insulin resistance: A study among non-diabetic acute coronary syndrome patients with impaired fasting glucose
Indian J Med Res 141, January 2015, pp 62-67 Serum lipoprotein ratios as markers of insulin resistance: A study among non-diabetic acute coronary syndrome patients with impaired fasting glucose S. Ray
More informationPattern of dyslipidemia and evaluation of non-hdl cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus
Original Article Nepal Med Coll J 2012; 14(4): 278-282 Pattern of dyslipidemia and evaluation of non-hdl cholesterol as a marker of risk factor for cardiovascular disease in type 2 diabetes mellitus A
More informationCurrent Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD
Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center
More informationThe Whitehall II study originally comprised 10,308 (3413 women) individuals who, at
Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationORIGINAL INVESTIGATION. Hemoglobin A 1c Level and Future Cardiovascular Events Among Women
ORIGINAL INVESTIGATION Hemoglobin A 1c Level and Future Cardiovascular Events Among Women Gavin J. Blake, MD, MPH, MSc, MRCPI; Aruna D. Pradhan, MD, MPH; JoAnn E. Manson, MD, DrPH; G. Rhys Williams, ScD;
More informationARIC Manuscript Proposal # 979. PC Reviewed: 11/21/03 Status: Rejected Priority: SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 979 PC Reviewed: 11/21/03 Status: Rejected Priority: SC Reviewed: Status: Priority: 1.a. Full Title: Factors of the metabolic syndrome and incidence of coronary heart disease,
More informationGlobal Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH
Diabetes Care Publish Ahead of Print, published online April 1, 2008 Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic Syndrome Khiet C. Hoang MD, Heli Ghandehari, BS, Victor
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL A Meta-analysis of LDL-C, non-hdl-c, and apob as markers of cardiovascular risk. Slide # Contents 2 Table A1. List of candidate reports 8 Table A2. List of covariates/model adjustments
More informationSUPPLEMENTAL MATERIAL. Materials and Methods. Study design
SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants,
More informationEugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG
Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationInflammation markers and metabolic characteristics of subjects with onehour plasma glucose levels
Diabetes Care Publish Ahead of Print, published online November 16, 2009 Inflammation markers and metabolic characteristics of subjects with onehour plasma glucose levels Gianluca Bardini, MD, PhD, Ilaria
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More information5/28/2010. Pre Test Question
Myth of Metabolic Syndrome? C. W. Spellman, DO, PhD Professor and Associate Dean Research Dir. Center Diabetes and Metabolic Disorders Department Internal Medicine, Div. Endocrinology Texas Tech University
More informationImpact of Chronicity on Lipid Profile of Type 2 Diabetics
Impact of Chronicity on Lipid Profile of Type 2 Diabetics Singh 1, Gurdeep & Kumar 2, Ashok 1 Ph.D. Research Scholar, Department of Sports Science, Punjabi University Patiala, India, Email: drgurdeep_sahni@yahoo.co.in
More informationThe inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema
The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,
More informationORIGINAL ARTICLE SUMMARY
ORIGINAL ARTICLE HIP CIRCUMFERENCE IS AN IMPORTANT PREDICTOR OF PLASMA C-REACTIVE PROTEIN LEVELS IN OVERWEIGHT AND OBESE TAIWANESE WOMEN Hei-Jen Jou 1,2, I-Ping Hsu 3, Pei-Ying Ling 1, Chia-Tzu Lin 1,
More informationOptimal cut-points of different anthropometric indices and their joint effect in prediction of type 2 diabetes: results of a cohort study
Zafari et al. BMC Public Health (2018) 18:691 https://doi.org/10.1186/s12889-018-5611-6 RESEARCH ARTICLE Open Access Optimal cut-points of different anthropometric indices and their joint effect in prediction
More informationFriends, Romans, Cardiac Practitioners, lend me your ears; I come here to bury LDL, not to praise him
Friends, Romans, Cardiac Practitioners, lend me your ears; I come here to bury LDL, not to praise him Adapted from Julius Caesar: Act 3, Scene 2, Page 4 An Alternative Viewpoint A Biomedical Approach to
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationSmoking and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes Mellitus
ORIGINAL INVESTIGATION Smoking and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes Mellitus Wael K. Al-Delaimy, MD, PhD; JoAnn E. Manson, MD, DrPH; Caren G. Solomon, MD, MPH; Ichiro Kawachi,
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationCardiovascular disease (CVD) is the
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Cost Effectiveness of Statin Therapy for the Primary Prevention of Major Coronary Events in Individuals With Type 2 Diabetes
More informationTreatment to reduce cardiovascular risk: multifactorial management
Treatment to reduce cardiovascular risk: multifactorial management Matteo Anselmino, MD PhD Assistant Professor San Giovanni Battista Hospital Division of Cardiology, Department of Internal Medicine University
More informationThe Impact of Diabetes Mellitus and Prior Myocardial Infarction on Mortality From All Causes and From Coronary Heart Disease in Men
Journal of the American College of Cardiology Vol. 40, No. 5, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02044-2
More informationApolipoprotein B and non-high-density lipoprotein cholesterol. and risk of coronary heart disease in Chinese
Apolipoprotein B and non-high-density lipoprotein cholesterol and risk of coronary heart disease in Chinese Chien et al. Apolipoprotein B in Chinese Kuo-Liong Chien, 1, * Hsiu-Ching Hsu, Ta-Chen Su, Ming-Fong
More informationTRENDS OF LIPID ABNORMALITIES IN PAKISTANI TYPE-2 DIABETES MELLITUS PATIENTS: A TERTIARY CARE CENTRE DATA
Original Article TRENDS OF LIPID ABNORMALITIES IN PAKISTANI TYPE-2 DIABETES MELLITUS PATIENTS: A TERTIARY CARE CENTRE DATA Sehran Mehmood Bhatti 1, Sajid Dhakam 2, Mohammad Attaullah Khan 3 ABSTRACT Objective:
More informationBefore the Pre. PREDIABETES Diagnosis, Management, Treatment. A few thoughts on diabetes.
PREDIABETES Diagnosis, Management, Treatment Before the Pre A few thoughts on diabetes. James Lenhard, MD Director, Diabetes and Metabolic Diseases Center Christiana Care Health System JLenhard@ChristianaCare.org
More informationCARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION
ORIGINAL ARTICLE CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION Sibasis Sahoo 1, Komal Shah 2,Anand Shukla 3, Jayesh Prajapati 3, Pratik
More informationLow-density lipoprotein as the key factor in atherogenesis too high, too long, or both
Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both Lluís Masana Vascular Medicine and Metabolism Unit. Sant Joan University Hospital. IISPV. CIBERDEM Rovira i Virgili
More informationARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority:
ARIC Manuscript Proposal #1233 PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: 1.a. Full Title: Subclinical atherosclerosis precedes type 2 diabetes in the ARIC study cohort
More informationFasting or non fasting?
Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics Which is best to measure Lower continues
More informationDepartment of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Mohali, 2
Original Article Complications Diabetes Metab J 2015 Forthcoming. Posted online 2015 pissn 2233-6079 eissn 2233-6087 DIABETES & METABOLISM JOURNAL Agreement between Framingham Risk Score and United Kingdom
More informationAlthough the prevalence and incidence of type 2 diabetes mellitus
n clinical n Validating the Framingham Offspring Study Equations for Predicting Incident Diabetes Mellitus Gregory A. Nichols, PhD; and Jonathan B. Brown, PhD, MPP Background: Investigators from the Framingham
More informationDiabetes Care 31: , 2008
Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S. KHIET C. HOANG, MD HELI GHANDEHARI VICTOR
More informationImpact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study
European Journal of Clinical Investigation (2002) 32, 924 930 Blackwell Science, Ltd Impact of diabetes duration and cardiovascular risk factors on mortality in type 2 diabetes: the Hoorn Study A. M. W.
More informationCorrelation between triglyceride level and carotid intima media thickness in patients with type 2 diabetes mellitus
International Journal of Clinical Trials Bendwal K et al. Int J Clin Trials. 2018 May;5(2):97-101 http://www.ijclinicaltrials.com pissn 2349-3240 eissn 2349-3259 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3259.ijct20181051
More informationObesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes
Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes Genetics, environment, and lifestyle (obesity, inactivity, poor diet) Impaired fasting glucose Decreased β-cell
More information